COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2982: Articles 29811-29820  | Next

Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study
Ma, L., Xie, W., Li, D., Shi, L., Mao, Y., Xiong, Y., Zhang, Y., Zhang, M.
10.1101/2020.03.21.20037267 — Posted: 2020-03-24 Discussion: Onsite
Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
Bian, H., Zheng, Z.-H., Wei, D., Zhang, Z., Kang, W.-Z., Hao, C.-Q., Dong, K., Kang, W., Xia, J.-L., Miao, J.-L., Xie, R.-H., Wang, B., Sun, X.-X., Yang, X.-M., Lin, P., Geng, J.-J., Wang, K., Cui, H.-Y., Zhang, K., Chen, X.-C., Tang, H., Du, H., Yao, N., Liu, S.-S., Liu, L.-N., Zhang, Z., Gao, Z.-W., Nan, G., Wang, Q.-Y., Lian, J.-Q., Chen, Z.-N., Zhu, P.
10.1101/2020.03.21.20040691 — Posted: 2020-03-24 Discussion: Onsite | Offsite
MATHEMATICAL PREDICTIONS FOR COVID-19 AS A GLOBAL PANDEMIC
Victor, A. O.
10.1101/2020.03.19.20038794 — Posted: 2020-03-24
First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients
Chen, H., Zhang, Z., Wang, L., Huang, Z., Gong, F., Li, X., Chen, Y., WU, J. J.
10.1101/2020.03.22.20034041 — Posted: 2020-03-24 Discussion: Onsite
Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan
Xie, C., Wang, X., Liu, H., Bao, Z., Yu, J., Zhong, Y., Chua, M. L.
10.1101/2020.03.21.20037051 — Posted: 2020-03-24
Characterizing occupations that cannot work from home: a means to identify susceptible worker groups during the COVID-19 pandemic
Baker, M. G.
10.1101/2020.03.21.20031336 — Posted: 2020-03-24
Estimating excess 1- year mortality from COVID-19 according to underlying conditions and age in England: a rapid analysis using NHS health records in 3.8 million adults
Banerjee, A., Pasea, L., Harris, S., Gonzalez-Izquierdo, A., Torralbo, A., Shallcross, L., Noursadeghi, M., Pillay, D., Pagel, C., Wong, W. K., Langenberg, C., Williams, B., Denaxas, S., Hemingway, H.
10.1101/2020.03.22.20040287 — Posted: 2020-03-24 Discussion: Onsite
Analysis of psychological state and clinical psychological intervention model of patients with COVID-19
Yang, L., Wu, D., Hou, Y., Wang, X., Dai, N., Wang, G., Yang, Q., Zhao, W., Lou, Z., Ji, Y., Ruan, L.
10.1101/2020.03.22.20040899 — Posted: 2020-03-24
High risk of infection caused posttraumatic stress symptoms in individuals with poor sleep quality: A study on influence of coronavirus disease (COVID-19) in China
Zhang, F., Shang, Z., Ma, H., Jia, Y., Sun, L., Guo, X., Wu, L., Sun, Z., Zhou, Y., Wang, Y., Liu, N., Liu, W.
10.1101/2020.03.22.20034504 — Posted: 2020-03-24
Tracking and forecasting milepost moments of the epidemic in the early-outbreak: framework and applications to the COVID-19
Wang, H., Zhang, Y., Lu, S., Wang, S.
10.1101/2020.03.21.20040139 — Posted: 2020-03-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).